News

Published on 3 May 2022 on Zacks via Yahoo Finance

MacroGenics (MGNX) Reports Q1 Loss, Lags Revenue Estimates


Article preview image

MacroGenics (MGNX) came out with a quarterly loss of $1.08 per share versus the Zacks Consensus Estimate of a loss of $0.84. This compares to loss of $0.90 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of -28.57%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.83 per share when it actually produced a loss of $0.95, delivering a surprise of -14.46%.

Over the last four quarters, the company has not been able to surpass consensus EPS estimates.

NASDAQ.XGN price evolution
NASDAQ.MGNX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Analyst Estimates: Here's What Brokers Think Of Exagen Inc. (NASDAQ:XGN) After Its Annual Report

A week ago, Exagen Inc. (NASDAQ:XGN) came out with a strong set of annual numbers that could pote...

Simply Wall St. via Yahoo Finance 21 Mar 2024

Exagen Inc. (NASDAQ:XGN) Q4 2023 Earnings Call Transcript

Exagen Inc. (NASDAQ:XGN) Q4 2023 Earnings Call Transcript March 18, 2024 Exagen Inc.  isn't one o...

Insider Monkey via Yahoo Finance 20 Mar 2024

Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates

Exagen Inc. (XGN) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Es...

Zacks via Yahoo Finance 19 Mar 2024

Zynex Inc. (ZYXI) Q4 Earnings and Revenues Miss Estimates

Zynex Inc. (ZYXI) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensu...

Zacks via Yahoo Finance 29 Feb 2024

Despite Fast-paced Momentum, Exagen Inc. (XGN) Is Still a Bargain Stock

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy ...

Zacks via Yahoo Finance 7 Feb 2024

Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates

Exagen Inc. (XGN) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Es...

Zacks via Yahoo Finance 8 Aug 2023

This Exagen Insider Increased Their Holding In The Last Year

From what we can see, insiders were net buyers in Exagen Inc.'s (NASDAQ:XGN ) during the past 12 ...

Simply Wall St. via Yahoo Finance 24 Jul 2023

Exagen Inc.'s (NASDAQ:XGN) Low P/S No Reason For Excitement

With a price-to-sales (or "P/S") ratio of 1.2x Exagen Inc. (NASDAQ:XGN) may be sending very bulli...

Simply Wall St. via Yahoo Finance 13 Jun 2023

Exagen (NASDAQ:XGN) shareholders are up 20% this past week, but still in the red over the last three...

Exagen Inc. (NASDAQ:XGN) shareholders will doubtless be very grateful to see the share price up 4...

Simply Wall St. via Yahoo Finance 16 May 2023

Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates

Exagen Inc. (XGN) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Es...

Zacks via Yahoo Finance 15 May 2023